MedTrace Logo

Dose-comparison Study of Prednisone in Heart Failure

NCT01559727 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-08-28

No results posted yet for this study

Summary

The purpose of this study is to examine the efficacy of three doses of prednisone, a glucocorticoid, in treatment of patients with symptomatic heart failure.

Conditions

Interventions

DRUG

prednisone

The patients with symptomatic heart failure are treated with prednisone at dose of 15 mg/day.

DRUG

prednisone

The patients with symptomatic heart failure are treated with prednisone at dose of 30 mg/day

DRUG

prednisone

The patients with symptomatic heart failure are treated with prednisone at dose of 60 mg/day

Sponsors & Collaborators

  • Hebei Medical University

    lead OTHER

Principal Investigators

  • Kunshen Liu, MD · The First Hospital of Hebei Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-01-31
Completion
2013-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01559727 on ClinicalTrials.gov